Skip to main content

Table 3 Muscle symptom presentation in patients with confirmed SAMSa and refuted SAMS in MUSE trial

From: Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects

  Confirmed SAMS (n = 20) Refuted SAMS (n = 51) p-value
Baseline muscle symptom intensity (VAS-scoreb), mean (SD) 4.5 (2.7) 4.7 (2.4) 0.84
Baseline muscle symptom characteristicsc    
Sensory dimension, mean (SD) 10.5 (5.7) 11.5 (7.1) 0.62
Affective dimension, mean (SD) 2.9 (2.1) 2.5 (2.6) 0.58
Total sum-score, mean (SD) 13.5 (7.1) 13.8 (9.2) 0.90
Muscle symptom location on statin treatmentd    
Bilateral muscle pain lower extremities, n (%) 15 (75) 21 (41) 0.01
Bilateral muscle pain upper extremities, n (%) 11 (55) 18 (35) 0.13
Bilateral muscle pain both regions, n (%) 8 (40) 9 (18) 0.05
  1. SD, standard deviations, aSAMS, statin associated muscle symptoms, bVAS-score, Visual Analog Scale, cMuscle symptom characteristics measured with Short-form McGill Pain Questionnaire, dMuscle symptom location measured with Margolis pain drawings